Document is current
Any future updates will be listed below
-
Authors
Farias, Rachel M.
Jiang, Yan
Levy, Erma J.
Hwang, Cindy
Wang, Jian
Burton, Elizabeth M.
Cohen, Lorenzo
Ajami, Nadim
Wargo, Jennifer A.
Daniel, Carrie R.
McQuade, Jennifer L.
-
Funding
Funding for this research was provided by:
Seerave Foundation, Rising Tide Foundation, the Mark Foundation for Cancer Research, MDA Melanoma SPORE Developmental Research Program Award, MDA Physician Scientist Program and MDA Moonshot Program
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 22 November 2024
First Online: 4 December 2024
Declarations
:
: Ethical approval for the study was obtained from The University of Texas MD Anderson Cancer Center Institutional Review Board (IRB). Participants are informed that they can withdraw their participation in the study at any time without disclosing reasons for their cancellation and without negative consequences for their future medical care. The MD Anderson Offices of Human Subjects Protection and Protocol Review and Reporting further support regulatory oversight, review, and monitoring of protocols. The trial has been registered at ClinicalTrials.gov (reference: NCT04645680).
: NA – The manuscript does not contain any reference or image pertaining to an individual or research participant.
: The authors declare no competing interests.
